Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Int J Antimicrob Agents. 2017 May;49(5):573-578. doi: 10.1016/j.ijantimicag.2017.01.011. Epub 2017 Mar 31.
The Bacteroides fragilis group constitute a significant portion of the human gut microbiota and comprise a major proportion of anaerobic bacteria isolated in human infections. We established a baseline of antimicrobial susceptibility rates in the B. fragilis group in the intestinal tract of relatively antibiotic-naive healthy Danish children. From 174 faecal samples collected from children attending day care, 359 non-duplicate isolates were screened for antimicrobial susceptibility. Of these, 0.0%, 1.9%, 5.0% and 21.2% of isolates were intermediate-susceptible or resistant to metronidazole, meropenem, piperacillin/tazobactam and clindamycin, respectively. Eighteen additional studies reporting susceptibility rates in the B. fragilis group bacteria were identified by conducting a literature search. Heterogeneity among results from studies of B. fragilis group antimicrobial susceptibility rates in faecal microbiota exists.
脆弱拟杆菌群构成了人类肠道微生物群的重要部分,并且是在人类感染中分离出的主要厌氧细菌。我们在相对无抗生素的丹麦健康儿童的肠道中建立了脆弱拟杆菌群的抗生素敏感性基准。从参加日托的 174 份粪便样本中,筛选了 359 种非重复分离株,以检测其对各种抗生素的敏感性。其中,分别有 0.0%、1.9%、5.0%和 21.2%的分离株对甲硝唑、美罗培南、哌拉西林/他唑巴坦和克林霉素表现出中介敏感性或耐药性。通过文献检索,确定了另外 18 项报告脆弱拟杆菌群细菌敏感性率的研究。在粪便微生物群中,脆弱拟杆菌群抗生素敏感性率的研究结果存在异质性。